Traws Pharma, Inc. — Director's Dealing 2013

Jul 25, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-24

Reporting Person: Kumar Ramesh (Director, President and CEO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	92911	Direct
Common Stock	150037	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Convertible Preferred Stock	$		Common Stock (4667)		Direct
Series B Convertible Preferred Stock	$		Common Stock (20645)		Direct
Series C Convertible Preferred Stock	$		Common Stock (983)		Direct
Series D Convertible Preferred Stock	$		Common Stock (2209)		Direct
Series E Convertible Preferred Stock	$		Common Stock (1084)		Direct
Series F Convertible Preferred Stock	$		Common Stock (500)		Direct
Series G Convertible Preferred Stock	$		Common Stock (765)		Direct
Series H Convertible Preferred Stock	$		Common Stock (500)		Direct
Series I Convertible Preferred Stock	$		Common Stock (100)		Direct
Stock Option (right to purchase)	$2.67	2016-01-01	Common Stock (5256)		Direct
Stock Option (right to purchase)	$6.00	2017-04-01	Common Stock (105026)		Direct
Stock Option (right to purchase)	$5.76	2020-03-17	Common Stock (18754)		Direct
Stock Option (right to purchase)	$5.76	2020-03-17	Common Stock (75018)		Direct
Stock Option (right to purchase)	$6.13	2020-12-10	Common Stock (52513)		Direct
Stock Option (right to purchase)	$6.13	2021-12-05	Common Stock (10335)		Direct
Stock Option (right to purchase)	$13.28	2022-12-19	Common Stock (93773)		Direct
Stock Option (right to purchase)	$13.28	2022-12-19	Common Stock (93773)		Direct

Footnotes

F1: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.80-for-1 basis and has no expiration date.

F2: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.85-for-1 basis and has no expiration date.

F3: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F4: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F5: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F6: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.77-for-1 basis and has no expiration date.

F7: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date

F8: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F9: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F10: This option, representing a right to purchase a total of 75,018 shares of Common Stock, is immediately exercisable and vests over 4 years from March 17, 2010, with 25% vesting on March 17, 2011 and 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.

F11: This option, representing a right to purchase a total of 93,773 shares of Common Stock, is immediately exercisable and vests over 4 years from December 18, 2012, with 25% vesting on December 18, 2013 and 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date

F12: The reporting person is the trustee of the trust.